Aaron Joesph Cooke, DPT | |
1288 S Governors Ave, Dover, DE 19904-4802 | |
(302) 677-0100 | |
(302) 677-0267 |
Full Name | Aaron Joesph Cooke |
---|---|
Gender | Male |
Speciality | Physical Therapy |
Experience | 19 Years |
Location | 1288 S Governors Ave, Dover, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437182672 | NPI | - | NPPES |
1437182672 | Medicaid | DE | |
88760501 | Other | NCA | |
2760814000 | Other | IBC | |
11590760 | Other | CAQH | |
5070-0062 | Other | CARE FIRST |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ati Holdings Llc | 9537112719 | 375 |
News Archive
Tyco International Ltd. today reported $0.55 in diluted earnings per share (EPS) from continuing operations for the fiscal fourth quarter of 2010 and diluted EPS from continuing operations before special items of $0.74 per share. Revenue in the quarter was $4.5 billion with organic revenue growth of 2% year-over-year. Cash from operating activities was $963 million and free cash flow was $598 million. These amounts included $39 million of cash outflows related to restructuring activities and acquisition-related costs.
The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction. Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.
The Accelerated Community Oncology Research Network (ACORN), a national oncology clinical trial network, has announced that it is bridging the disparity gap in healthcare to underserved communities by enrolling more than double the national average of African Americans in cancer-related clinical trials.
VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development.
Nerve cells, or neurons - specifically the "workhorse cells" involved in walking, breathing and chewing - can adjust to changes in the body, but they never stop working unless there is an fatal injury.
› Verified 1 days ago
Provider Name | Ati Holdings Llc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061101000380 |
News Archive
Tyco International Ltd. today reported $0.55 in diluted earnings per share (EPS) from continuing operations for the fiscal fourth quarter of 2010 and diluted EPS from continuing operations before special items of $0.74 per share. Revenue in the quarter was $4.5 billion with organic revenue growth of 2% year-over-year. Cash from operating activities was $963 million and free cash flow was $598 million. These amounts included $39 million of cash outflows related to restructuring activities and acquisition-related costs.
The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction. Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.
The Accelerated Community Oncology Research Network (ACORN), a national oncology clinical trial network, has announced that it is bridging the disparity gap in healthcare to underserved communities by enrolling more than double the national average of African Americans in cancer-related clinical trials.
VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development.
Nerve cells, or neurons - specifically the "workhorse cells" involved in walking, breathing and chewing - can adjust to changes in the body, but they never stop working unless there is an fatal injury.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Aaron Joesph Cooke, DPT 790 Remington Blvd, Bolingbrook, IL 60440-4909 Ph: () - | Aaron Joesph Cooke, DPT 1288 S Governors Ave, Dover, DE 19904-4802 Ph: (302) 677-0100 |
News Archive
Tyco International Ltd. today reported $0.55 in diluted earnings per share (EPS) from continuing operations for the fiscal fourth quarter of 2010 and diluted EPS from continuing operations before special items of $0.74 per share. Revenue in the quarter was $4.5 billion with organic revenue growth of 2% year-over-year. Cash from operating activities was $963 million and free cash flow was $598 million. These amounts included $39 million of cash outflows related to restructuring activities and acquisition-related costs.
The U.S. Food and Drug Administration's approval of Alkermes' opioid dependence medication (VIVITROL) for the prevention of relapse to opioid dependence following opioid detoxification is positive news for families of young adults and all those who are struggling to overcome opioid addiction. Addiction, a disease of the human brain, is a chronic illness while opioid dependence is frequently characterized by relapse.
The Accelerated Community Oncology Research Network (ACORN), a national oncology clinical trial network, has announced that it is bridging the disparity gap in healthcare to underserved communities by enrolling more than double the national average of African Americans in cancer-related clinical trials.
VantAI and TARA Biosystems today announced the launch of a biology-driven, AI-enabled collaboration for accelerated cardiac drug development.
Nerve cells, or neurons - specifically the "workhorse cells" involved in walking, breathing and chewing - can adjust to changes in the body, but they never stop working unless there is an fatal injury.
› Verified 1 days ago
Adrianne Greene, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 Fax: 302-677-0267 | |
Ms. Amy Kathryn Tullis, PT, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 97 Commerce Way, Suite 101, Dover, DE 19904 Phone: 302-734-8000 | |
Jihwan Jeong, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 | |
Matthew Vassalotti, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 Fax: 302-677-0267 | |
Kathy Tompkins, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 945 Forest St, Dover, DE 19904 Phone: 302-672-1500 | |
Christine Marie Reynolds, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1203 Walker Rd, Dover, DE 19904 Phone: 302-735-8800 | |
Katherine Marie Monahan, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1288 S Governors Ave, Dover, DE 19904 Phone: 302-677-0100 |